Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common side effects on the first day of Mounjaro are nausea, mild stomach discomfort, and fatigue — most people find these settle within a few days as the body adjusts to tirzepatide's effect on gastric emptying. They tend to be lightest at the 2.5mg starting dose. That said, Mounjaro is a prescription-only medicine, and a GPhC-registered prescriber weighs up your full health picture before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Your DPD notification pings, the plain unbranded box lands on the doorstep, and inside is a KwikPen that's been refrigerated through the supply chain. Before the first injection, it's worth knowing that whatever happens in the next 24 hours is almost certainly temporary and dose-related, not a sign something has gone wrong.
The 2.5mg starting dose is the lowest in the licensed schedule precisely because it gives your system time to adapt. Many people inject in the evening so that any queasiness arrives overnight rather than mid-afternoon. Others prefer the morning. There's no single right answer, but the timing choice is yours to discuss with your prescriber, and our clinical team covers exactly this when you start through our consultation process.
The injection itself (into the abdomen, thigh, or upper arm) is brief. The pen is pre-filled; there's no measuring and no mixing. Most people report the needle is finer than expected. Injection-site redness or a small lump at the site can appear and typically resolves within hours. Rotating sites between doses reduces this.
Tirzepatide's side-effect profile is well-characterised from the SURMOUNT clinical programme, which involved thousands of adults over 72 weeks. The NHS tirzepatide medicines page lists the very common effects (affecting more than 1 in 10 people): nausea, diarrhoea, vomiting, constipation, stomach pain, indigestion, and injection-site reactions. On day one specifically, nausea tends to be the loudest complaint, tirzepatide activates GIP and GLP-1 receptors that signal fullness and slow the stomach's passage of food, so even a normal-sized meal can feel heavier than usual.
Fatigue and mild headache also appear early, likely a downstream effect of reduced food intake and the body recalibrating. These are not reasons to stop; they're the body doing exactly what the medicine is designed to prompt. What helps: eating smaller portions, choosing lower-fat foods, staying well hydrated, and avoiding lying down immediately after eating. Our guide to side effects across the first week covers how this picture typically evolves beyond day one, and if you want to know what to expect specifically around the third day, our page on Mounjaro day 3 side effects walks through how symptoms often shift as the medicine settles in.
Burping (sometimes prominent) catches people off guard. It's a direct consequence of delayed gastric emptying and usually settles as the gut adjusts. If you find the first-day side effects of Mounjaro unexpectedly intense, don't adjust your dose or timing without speaking to your prescriber first.
Most first-day discomfort is mild and self-limiting. A small number of people, however, experience symptoms that need prompt attention. Know the difference before you inject.
Get same-day medical help if you develop severe stomach pain that doesn't ease and spreads towards your back, with or without vomiting. This pattern can indicate acute pancreatitis. Following a review of global safety data, the MHRA issued a Drug Safety Update in January 2026 specifically highlighting pancreatitis as an infrequent but serious risk with GLP-1 medicines. It is rare, but it is worth knowing the warning sign.
Call 999 or go to A&E for signs of a serious allergic reaction: swelling of the face, lips, or throat; difficulty breathing; rapid heartbeat alongside a rash. Call your GP or 111 if you experience dehydration from persistent vomiting or diarrhoea, losing fluids quickly can affect the kidneys. Sudden changes in vision or severe dizziness also warrant a call.
If you've had symptoms you weren't expecting and want to flag them to the regulator directly, the MHRA Yellow Card scheme accepts reports from patients as well as healthcare professionals. Every report contributes to the ongoing safety picture for tirzepatide in the UK. For broader context on what to expect, our full Mounjaro side-effects guide goes into more depth across the titration schedule.
People researching what tirzepatide feels like on day one often arrive at online forums and come away alarmed by a handful of vivid accounts. Clinical trial populations tell a broader story: most participants stayed on treatment, and the side effects reported were predominantly mild to moderate, particularly at the starter dose.
Knowing this doesn't make nausea pleasant. It does make it manageable. A question our prescribers field regularly: "Should I eat before injecting?" Eating a small, low-fat meal beforehand rather than injecting on an empty stomach can help with nausea for some people. Protein and fibre matter more than usual because appetite drops significantly, and muscle needs to be supported, something to raise with your prescriber if you're not sure how to adjust your diet at the start.
Mounjaro is not suitable for everyone, and a prescriber's role isn't just to hand over a pen. At nume, a named GPhC-registered Independent Prescriber reads every consultation personally, your medical history, any other medicines you take, and questions like the timing of your contraception if relevant. You can learn more about how Mounjaro works or read about tirzepatide's broader side-effect profile to go into your consultation better prepared. Our prescribers discuss suitability and side effects as part of every assessment, check your eligibility to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.